Trulieve releases investor presentation outlining US medical cannabis footprint, growth catalysts

Trulieve Cannabis Corp.

Trulieve Cannabis Corp.

TRLV

0.00
  • Trulieve outlined its NYSE listing under ticker TRLV on June 10, 2026, following U.S. medical marijuana rescheduling to Schedule III in April 2026.
  • Corporate restructuring on June 3, 2026 deconsolidated “Harvest” mixed-use operations to support the listing; Trulieve retained a 90% economic interest.
  • Consolidated business now focuses on DEA-registered, state-licensed medical operations: 206 dispensaries, 3.5 million square feet of cultivation and processing capacity.
  • 2025 consolidated results: USD 1.2 billion revenue, 60% gross margin, USD 273 million operating cash flow.
  • Growth priorities include Georgia program expansion with pharmacy distribution from July 1, 2026, Texas buildout pending final license approval expected in 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trulieve Cannabis Corp. published the original content used to generate this news brief on July 10, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.